Snus carries real health risks, but they are substantially lower than those from smoking cigarettes. A panel of experts estimated that the total mortality risk from using low-nitrosamine smokeless tobacco like Swedish snus falls between 5% and 10% of the risk associated with smoking. That means snus is not harmless, but it occupies a very different tier of danger than cigarettes. The specific risks worth knowing about involve your mouth, your heart and blood vessels, your metabolic health, and the addictive nature of nicotine itself.
What the FDA Actually Says
The U.S. Food and Drug Administration has authorized eight General Snus products to carry a specific reduced-risk claim: “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” That authorization, renewed through November 2032, came after rigorous scientific review. It’s worth noting what the FDA is and isn’t saying here. The claim is comparative, not absolute. Snus is lower risk than cigarettes. The FDA explicitly does not permit marketing that suggests these products are safe or FDA-endorsed.
Cancer Risk Is Lower Than You’d Expect
The cancer profile of snus surprised many researchers. Two studies evaluating oral cancer in snus users found no increased risk compared to non-users. A European study also found no increased risk of esophageal cancer. This is a sharp departure from cigarettes, which dramatically raise the risk of both.
Pancreatic cancer is the exception. Two large European cohort studies found a significant positive association between snus use and pancreatic cancer, and this held up even after adjusting for smoking and alcohol use. Swedish snus does contain tobacco-specific nitrosamines, the compounds most linked to cancer in smokeless tobacco. Levels of up to 1,190 nanograms of NNN and 120 nanograms of NNK per pouch have been measured. These are known carcinogens, just present at far lower concentrations than in cigarette smoke.
The Cardiovascular Picture Is Complicated
Each time you use snus, your blood pressure and heart rate temporarily spike. That’s the nicotine doing its job as a stimulant. Over the long term, though, chronic snus users don’t show significantly different resting blood pressure or heart rate compared to non-users. In one study, the numbers were nearly identical: systolic blood pressure of about 124 mmHg in both groups, heart rates within one beat per minute of each other.
The subtler problem is what’s happening inside your arteries. Chronic snus users show significantly higher arterial stiffness, a measure of how rigid your blood vessel walls have become. This stiffness is one of the strongest predictors of future cardiovascular events. Researchers found that the arterial aging effect of snus use was comparable to roughly 9 to 17 extra years of aging, depending on the measurement used. Snus users also showed impaired blood vessel dilation, meaning their arteries don’t relax as well when blood flow increases.
This may explain a troubling pattern in the data: snus users don’t appear to have a higher overall risk of having a heart attack or stroke, but those who do have one are more likely to die from it. If your blood vessels can’t dilate properly during a cardiac emergency, the consequences are worse.
Type 2 Diabetes Risk Rises With Heavy Use
A pooled analysis of five large cohort studies found that current snus users had a 15% higher risk of developing type 2 diabetes compared to people who never used snus. That’s a modest bump at average consumption levels. But the risk climbs steeply with heavier use. People consuming five to six boxes per week had a 42% higher risk. At seven or more boxes per week, the risk was 68% higher. Each additional box per week added about 8% to the risk. The mechanism likely involves nicotine’s effects on insulin sensitivity, though the exact pathway is still being studied.
Your Mouth Takes the Most Visible Hit
The most common and most visible effect of snus is what happens to the tissue where you place it. Among Scandinavian users, the prevalence of snuff-induced lesions, white patches or thickened tissue at the placement site, approaches 100%. A Norwegian study of young adults found that 79.2% of daily snus users had oral mucosal changes.
Gum recession is the other major oral consequence. One study found that 23.5% of loose snus users experienced receding gums, compared to just 2.9% of pouch snus users. The pouch format appears to be gentler on gum tissue, likely because the tobacco isn’t in direct granular contact with the gums. Asian studies of smokeless tobacco users in general found about 1.7 times higher odds of gum recession compared to non-users.
The encouraging news is that many of these oral changes improve or resolve after you stop using snus. The mucosal lesions in particular tend to fade. Gum recession, however, doesn’t reverse on its own, since receded gum tissue doesn’t grow back without dental intervention.
Nicotine Delivery and Addiction
Snus delivers nicotine to your bloodstream at levels comparable to cigarettes, just more slowly. A cigarette gets nicotine to peak blood levels in about 7 minutes. Snus takes roughly an hour. But the total amount absorbed is similar. In pharmacokinetic testing, a pouched snus product with 14.7 mg of nicotine produced a peak blood concentration of 13.4 ng/ml, nearly identical to the 12.8 ng/ml from a cigarette with 14.6 mg of nicotine.
This slower absorption curve means snus is less likely to produce the sharp “hit” of a cigarette, but it still builds and sustains nicotine dependence effectively. The slower delivery doesn’t make it easier to quit. People who try to stop using snus commonly report irritability, depression, restlessness, difficulty concentrating, insomnia, headaches, dizziness, sugar cravings, weight gain, and stomach upset.
Quitting Snus
A long-term Swedish follow-up study found that among snus users who attempted to quit, about half succeeded. Interestingly, none of the participants reported using any form of professional cessation support. They quit on their own or with help from friends and family. This suggests that while snus dependence is real, it may be somewhat more manageable than cigarette addiction for some people, though the withdrawal symptoms can still be significant and unpleasant.
Pregnancy and Birth Outcomes
For pregnant women, the picture is more reassuring than it is for smoking, but not risk-free. A large Swedish sibling study, which compared pregnancies in the same mother with and without snus use, found that continuous snus use during pregnancy reduced birth weight by about 20 grams. That’s a small effect and was not statistically significant. For context, smoking during pregnancy reduces birth weight by a much larger margin. Women who quit snus after the first trimester showed no meaningful difference in birth weight. The sibling design of this study is important because it controls for genetic and lifestyle factors that could otherwise skew the results.
How Snus Compares to Cigarettes
The comparison matters because many people find this article while deciding whether to switch. An expert panel convened by the American Association for Cancer Research estimated that for people aged 35 to 49, the total mortality risk from low-nitrosamine smokeless tobacco was about 9% of the risk of smoking. For those 50 and older, it dropped to about 5%. That translates to at least a 90% reduction in relative risk when switching from cigarettes to snus.
That’s a massive difference, and it explains why some public health researchers view snus as a viable harm reduction tool. Sweden, where snus is widely used and smoking rates are among the lowest in Europe, is often cited as a natural experiment supporting this position. But a 90% reduction in risk is not the same as no risk. Snus still raises your chances of pancreatic cancer, stiffens your arteries, damages your gum tissue, and creates a nicotine dependence that roughly half of people who try to quit will struggle to break.